Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial
- PMID: 20490908
- PMCID: PMC2944957
- DOI: 10.1007/s10461-010-9712-1
Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial
Abstract
Non-occupational post-exposure prophylaxis (nPEP) use is an HIV prevention strategy that has been recommended by the CDC to prevent HIV infection after a high risk sexual exposure since 1997. In a behavioral intervention trial of 4,295 MSM we assessed perceptions and use of nPEP over 4 years in six cities across the United States. Overall, 1.9% of MSM reported use of nPEP prior to enrollment, and 6.3% at least once during the trial. Awareness of nPEP was reported by 47.5%, with higher awareness in two sites with funded nPEP programs. Three seroconversions occurred in the 384 visits where nPEP courses were reported, with no effect of nPEP on risk of HIV acquisition in this cohort (hazard ratio = 0.91, 95% confidence interval [0.29, 2.86]). NPEP users were a riskier group: increased odds of nPEP use were observed in association with multiple partners and unprotected receptive and insertive anal sex with HIV infected partners and partners with unknown HIV status. NPEP use was also associated with use of illicit drugs (injection drugs, crack cocaine, hallucinogens, and amphetamines). Importantly, willingness to use nPEP after high risk sex was associated with lower odds of high risk sex. After an episode of nPEP use, nPEP users remained more likely to report high risk sex than those in this cohort who had not previously used nPEP. However, within the subset of people who had previously reported high risk sex, previous nPEP use was not associated with higher odds of high risk sex, thus allaying fears that availability of nPEP would lead to an increase in high risk sex.
Similar articles
-
Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013.AIDS Patient Care STDS. 2015 Jan;29(1):20-5. doi: 10.1089/apc.2014.0154. AIDS Patient Care STDS. 2015. PMID: 25369451 Free PMC article.
-
Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada.HIV Med. 2016 Oct;17(9):662-73. doi: 10.1111/hiv.12369. Epub 2016 Aug 1. HIV Med. 2016. PMID: 27477994 Free PMC article.
-
HIV Nonoccupational Postexposure Prophylaxis Among Men Who Have Sex with Men: A Systematic Review and Meta-Analysis of Global Data.AIDS Patient Care STDS. 2020 May;34(5):193-204. doi: 10.1089/apc.2019.0313. AIDS Patient Care STDS. 2020. PMID: 32396477
-
Characteristics, sexual practices and sexually transmissible infections diagnoses of men who have sex with men and use non-occupational HIV post-exposure prophylaxis in Victoria, Australia.Sex Health. 2016 Nov;13(6):555-559. doi: 10.1071/SH16092. Sex Health. 2016. PMID: 27537936
-
Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.AIDS. 2014 Jul 17;28(11):1545-54. doi: 10.1097/QAD.0000000000000301. AIDS. 2014. PMID: 24785956 Free PMC article. Review.
Cited by
-
A mixed methods study of non-occupational post-exposure prophylaxis at an STI clinic in Singapore: Five-year retrospective analysis and providers' perspectives.PLoS One. 2018 Aug 20;13(8):e0202267. doi: 10.1371/journal.pone.0202267. eCollection 2018. PLoS One. 2018. PMID: 30125333 Free PMC article.
-
Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China.BMC Public Health. 2021 Jun 24;21(1):1220. doi: 10.1186/s12889-021-11286-7. BMC Public Health. 2021. PMID: 34167509 Free PMC article.
-
Expert consensus statement on the science of HIV in the context of criminal law.J Int AIDS Soc. 2018 Jul;21(7):e25161. doi: 10.1002/jia2.25161. J Int AIDS Soc. 2018. PMID: 30044059 Free PMC article.
-
Post-exposure prophylaxis awareness and use among men who have sex with men in London who use geosocial-networking smartphone applications.AIDS Care. 2017 May;29(5):579-586. doi: 10.1080/09540121.2016.1259455. Epub 2016 Dec 2. AIDS Care. 2017. PMID: 27910722 Free PMC article.
-
A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.AIDS Patient Care STDS. 2012 Jun;26(6):320-8. doi: 10.1089/apc.2011.0432. AIDS Patient Care STDS. 2012. PMID: 22680280 Free PMC article.
References
-
- Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007;146(8):591–601. - PubMed
-
- Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54(RR-2):1–20. - PubMed
-
- Schechter M, do Lago RF, Mendelsohn AB, Moreira RI, Moulton LH, Harrison LH. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr. 2004;35(5):519–525. doi: 10.1097/00126334-200404150-00010. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- N01 CA035176/CA/NCI NIH HHS/United States
- N01 AI045200/AI/NIAID NIH HHS/United States
- U01 AI48016/AI/NIAID NIH HHS/United States
- U01 AI046749/AI/NIAID NIH HHS/United States
- U01 AI048040/AI/NIAID NIH HHS/United States
- N01 AI35176/AI/NIAID NIH HHS/United States
- U01 AI47981/AI/NIAID NIH HHS/United States
- U01 AI48040/AI/NIAID NIH HHS/United States
- U01 AI068617/AI/NIAID NIH HHS/United States
- U01 AI47995/AI/NIAID NIH HHS/United States
- U01 AI048016/AI/NIAID NIH HHS/United States
- U01 AI047995/AI/NIAID NIH HHS/United States
- N01 AI45200/AI/NIAID NIH HHS/United States
- N01 AI35173/AI/NIAID NIH HHS/United States
- U01 AI46749/AI/NIAID NIH HHS/United States
- N01 AI035173/AI/NIAID NIH HHS/United States
- U01 AI047981/AI/NIAID NIH HHS/United States